Showing results (701-710 of 902) with videos related to
Sort By:
Pageof 91
Plos One|October 14, 2014
MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trialThomas Pavelitz, Lindsay Renfro, Nathan R Foster, et al.NMR in Biomedicine|September 11, 2012
Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS studyJing Qi, Yuman Fong, Leonard Saltz, et al.Cancer|October 6, 2005
Developing a cancer-specific geriatric assessment: a feasibility studyArti Hurria, Supriya Gupta, Marjorie Zauderer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancerDaniel J Sargent, Claus Henning Köhne, Hanna Kelly Sanoff, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2023
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trialsJ Taieb, F A Sinicrope, L Pederson, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2018
Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance)Erin L Van Blarigan, Fang-Shu Ou, Donna Niedzwiecki, et al.Annals of Surgical Oncology|January 5, 2002
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancerA T Culliford, A D Brooks, S Sharma, et al.The Oncologist|November 9, 2016
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803Donna Niedzwiecki, Rian M Hasson, Heinz-Josef Lenz, et al.British Journal of Cancer|August 1, 2013
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomasJ K Lee, M Capanu, E M O'Reilly, et al.IEEE Journal of Biomedical and Health Informatics|July 2, 2020
AI in Medical Imaging Informatics: Current Challenges and Future DirectionsAndreas S Panayides, Amir Amini, Nenad D Filipovic, et al.Pageof 91